{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:19:38Z","timestamp":1771877978109,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12325-015-0239-8","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T11:08:11Z","timestamp":1443092891000},"page":"809-822","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat\u00ae Inhaler in Patients with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1007","volume":"32","author":[{"given":"Ren\u00e9","family":"Aalbers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Reza","family":"Maleki-Yazdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Waitere-Wijker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria C.","family":"Amatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Bjermer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,24]]},"reference":[{"key":"239_CR1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2014. Available at: http:\/\/www.goldcopd.org\/uploads\/users\/files\/GOLD_Report2014_Feb07.pdf . Last updated 2014. Accessed July 22, 2015."},{"key":"239_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1465-9921-14-49","volume":"14","author":"DP Tashkin","year":"2013","unstructured":"Tashkin DP, Ferguson GT. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respir Res. 2013;14:49.","journal-title":"Respir Res"},{"key":"239_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1586\/17476348.2014.910457","volume":"8","author":"ED Bateman","year":"2014","unstructured":"Bateman ED, Mahler DA, Vogelmeier CF, Wedzicha JA, Patalano F, Banerji D. Recent advances in COPD disease management with fixed-dose long-acting combination therapies. Expert Rev Respir Med. 2014;8:357\u201379.","journal-title":"Expert Rev Respir Med."},{"key":"239_CR4","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","volume":"359","author":"DP Tashkin","year":"2008","unstructured":"Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543\u201354.","journal-title":"N Engl J Med"},{"key":"239_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.110.167007","volume":"334","author":"T Bouyssou","year":"2010","unstructured":"Bouyssou T, Casarosa P, Naline E, et al. Pharmacological characterization of olodaterol, a novel inhaled \u03b2 2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models. J Pharmacol Exp Ther. 2010;334:53\u201362.","journal-title":"J Pharmacol Exp Ther"},{"key":"239_CR6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.pupt.2011.07.006","volume":"24","author":"JA Noord van","year":"2011","unstructured":"van Noord JA, Smeets JJ, Drenth BM, et al. 24-hour bronchodilation following a single dose of the novel \u03b22-agonist olodaterol in COPD. Pulm Pharmacol Ther. 2011;24:666\u201372.","journal-title":"Pulm Pharmacol Ther"},{"key":"239_CR7","unstructured":"Ferguson G, Feldman G, Hofbauer P, et al. Lung function efficacy of olodaterol QD delivered via Respimat\u00ae in COPD patients: Results from two 48-week studies. Eur Respir J. 2013;42 (Suppl 57):5s, abs 187."},{"key":"239_CR8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/COPD.S62502","volume":"9","author":"A Koch","year":"2014","unstructured":"Koch A, Pizzichini E, Hamilton A, et al. Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat\u00ae versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies. Int J Chron Obstruct Pulmon Dis. 2014;9:697\u2013714.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"239_CR9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/2193-1801-3-419","volume":"3","author":"GJ Feldman","year":"2014","unstructured":"Feldman GJ, Bernstein JA, Hamilton A, Nivens MC, Korducki L, LaForce C. The 24-h FEV1 time profile of olodaterol once daily via Respimat\u00ae and formoterol twice daily via Aerolizer\u00ae in patients with GOLD 2\u20134 COPD: results from two 6-week crossover studies. Springerplus. 2014;3:419.","journal-title":"Springerplus."},{"key":"239_CR10","first-page":"196","volume":"4","author":"P Lange","year":"2014","unstructured":"Lange P, Aumann J-L, Hamilton A, Tetzlaff K, Ting N, Derom E. The 24 hour lung function time profile of olodaterol once daily versus placebo and tiotropium in patients with moderate to very severe chronic obstructive pulmonary disease. J Pulm Respir Med. 2014;4:196.","journal-title":"J Pulm Respir Med."},{"key":"239_CR11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/13543784.2014.876409","volume":"23","author":"J Miguel-D\u00edez de","year":"2014","unstructured":"de Miguel-D\u00edez J, Jim\u00e9nez-Garc\u00eda R. Considerations for new dual-acting bronchodilator treatments for chronic obstructive pulmonary disease. Expert Opin Investig Drugs. 2014;23:453\u20136.","journal-title":"Expert Opin Investig Drugs"},{"key":"239_CR12","unstructured":"Maltais F, Beck E, Webster D, et al. Four weeks once daily treatment with tiotropium+olodaterol (BI 1744) fixed dose combination compared with tiotropium in COPD patients. Eur Respir J. 2010;36 (Suppl 54):1014s, abs 5557."},{"key":"239_CR13","doi-asserted-by":"crossref","unstructured":"Buhl R, Abrahams R, Bjermer L, et al. Pooled safety analysis of once-daily tiotropium and olodaterol fixed-dose combination via the Respimat in patients with chronic obstructive pulmonary disease: two 1-year studies. Chest. 2014;146 (No. 4 Meeting Abstracts):48A.","DOI":"10.1378\/chest.1994476"},{"key":"239_CR14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.rmed.2015.02.012","volume":"109","author":"MR Maleki-Yazdi","year":"2015","unstructured":"Maleki-Yazdi MR, Beck E, Hamilton AL, Korducki L, Koker P, Fogarty C. A randomised, placebo-controlled, Phase II, dose-ranging trial of once-daily treatment with olodaterol, a novel long-acting \u03b22-agonist, for 4\u00a0weeks in patients with chronic obstructive pulmonary disease. Respir Med. 2015;109:596\u2013605.","journal-title":"Respir Med"},{"key":"239_CR15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jcph.215","volume":"54","author":"JM Hohlfeld","year":"2014","unstructured":"Hohlfeld JM, Sharma A, van Noord JA, et al. Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease. J Clin Pharmacol. 2014;54:405\u201314.","journal-title":"J Clin Pharmacol"},{"key":"239_CR16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1183\/09031936.00136014","volume":"45","author":"R Buhl","year":"2015","unstructured":"Buhl R, Maltais F, Abrahams R, et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2\u20134). Eur Respir J. 2015;45:969\u201379.","journal-title":"Eur Respir J"},{"key":"239_CR17","unstructured":"Bouyssou T, Casarosa P, Pieper M, Schnapp A, Gantner F. Synergistic bronchoprotective activity of the long-acting beta 2-agonist olodaterol with tiotropium (long-acting M3 antagonist) and ciclesonide (inhaled steroid) on the ovalbumin-induced bronchoconstriction in anaesthetized guinea pigs. Eur Respir J. 2011;38 (Suppl 55):613s, abs 3451."},{"key":"239_CR18","unstructured":"Derom E, Westerman J, Groenke L, Hamilton A, Li C, Beeh KM. The 24-hour lung function profile of once-daily tiotropium and olodaterol fixed-dose combination compared with placebo and monotherapies in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189, abs A6727."},{"key":"239_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pupt.2015.04.002","volume":"32","author":"K-M Beeh","year":"2015","unstructured":"Beeh K-M, Westerman J, Kirsten A-M, et al. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2015;32:53\u20139.","journal-title":"Pulm Pharmacol Ther"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-015-0239-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T23:03:40Z","timestamp":1567206220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-015-0239-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1007\/s12325-015-0239-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}